---
figid: PMC12071316__cancers-17-01576-g001
figtitle: GLP-1 receptors in prostate cancer carcinogenesis (anti-tumorigenic effect)
  via mTOR-dependent signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12071316
filename: cancers-17-01576-g001.jpg
figlink: /pmc/articles/PMC12071316/figure/F1/
number: F1
caption: 'Role of GLP-1 receptors in prostate cancer carcinogenesis (anti-tumorigenic
  effect) via mTOR-dependent signaling pathway. GLP-1 receptors are expressed in human
  prostate tissues and cell lines. GLP-1 receptor agonists increase AMPK phosphorylation,
  leading to a decrement in the levels of p-mTOR 9. This promotes an anti-tumorigenic
  effect through suppression of cancer cell proliferation and invasion. Abbreviations:
  GLP-1—glucagon-like peptide 1, R—receptor, GIP—glucose-dependent insulinotropic
  polypeptide, AMPK—5′AMP-activated protein kinase, mTOR—mechanistic target of rapamycin,
  PKA—phosphokinase A, cAMP—cyclic adenosine monophosphate'
papertitle: May Patients Receiving GLP-1 Agonists Be at Lower Risk of Prostate Cancer
  Aggressiveness and Progression?
reftext: Julia Drewa, et al. Cancers (Basel). 2025 May;17(9).
year: '2025'
doi: 10.3390/cancers17091576
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: GLP-1 | GIP | prostate cancer | obesity | pathogenesis | agonists
automl_pathway: 0.8685415
figid_alias: PMC12071316__F1
figtype: Figure
redirect_from: /figures/PMC12071316__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12071316__cancers-17-01576-g001.html
  '@type': Dataset
  description: 'Role of GLP-1 receptors in prostate cancer carcinogenesis (anti-tumorigenic
    effect) via mTOR-dependent signaling pathway. GLP-1 receptors are expressed in
    human prostate tissues and cell lines. GLP-1 receptor agonists increase AMPK phosphorylation,
    leading to a decrement in the levels of p-mTOR 9. This promotes an anti-tumorigenic
    effect through suppression of cancer cell proliferation and invasion. Abbreviations:
    GLP-1—glucagon-like peptide 1, R—receptor, GIP—glucose-dependent insulinotropic
    polypeptide, AMPK—5′AMP-activated protein kinase, mTOR—mechanistic target of rapamycin,
    PKA—phosphokinase A, cAMP—cyclic adenosine monophosphate'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GLP1R
  - GCG
  - ZGLP1
  - GIP
  - GNAI2
  - C1QTNF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - MTOR
  - SEMA6A
  - agonists
  - cancer
  - prostate cancer
---
